Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Pepsin release by prostaglandin E1 analogue. A potential therapeutic problem.

Basson MD, Zucker KA, Adrian TE, Zdon MJ, Ballantyne GH, Modlin IM.

Arch Surg. 1988 Apr;123(4):431-3.

PMID:
3126724
2.

Prostaglandin E analogue inhibition of intrinsic factor release.

Zucker KA, Adrian TE, Ballantyne GH, Modlin IM.

Scand J Gastroenterol. 1988 Aug;23(6):650-4.

PMID:
3140367
3.

Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue.

Howden CW, Burget DW, Silletti C, Van Eeden A, Tomkins KB, Hunt RH.

Aliment Pharmacol Ther. 1987 Aug;1(4):305-13.

PMID:
2979675
4.

Effects of misoprostol on histamine-related gastric secretion in man.

Wilson DE, Wilson PC.

J Assoc Acad Minor Phys. 1989;1(1):16-8.

PMID:
2520847
6.

Cyclo-oxygenase-1 inhibition increases acid secretion by modulating H+,K+-ATPase expression and activation in rabbit parietal cells.

Nandi J, Das PK, Zinkievich JM, Baltodano JD, Levine RA.

Clin Exp Pharmacol Physiol. 2009 Feb;36(2):127-34. doi: 10.1111/j.1440-1681.2008.05032.x. Epub 2008 Aug 26.

PMID:
18759857
8.

Effects of misoprostol on gastric pepsin secretion and human mucosal cell loss in man.

Quadros E, Wilson DE.

J Assoc Acad Minor Phys. 1990;1(2):17-9.

PMID:
2135692
9.
10.

Demonstration of specific E-type prostaglandin receptors using enriched preparations of canine parietal cells and [3H]misoprostol free acid.

Tsai BS, Kessler LK, Schoenhard G, Collins PW, Bauer RF.

Am J Med. 1987 Jul 27;83(1A):9-14.

PMID:
2887113
11.

E-type prostaglandin binding sites in isolated canine parietal cells: elucidation with (3H) misoprostol free acid.

Tsai BS, Kessler LK, Schoenhard G, Collins PW, Bauer RF.

Z Gastroenterol. 1987 Apr;25(4):201-6.

PMID:
2884786
12.

Pepsins, peptic activity, and peptic inhibitors.

Samloff IM.

J Clin Gastroenterol. 1981;3(Suppl 2):91-4.

PMID:
6119339
13.

Intracellular coupling of prostaglandin inhibition of acid secretion in isolated rabbit gastric parietal cells.

Choquet A, Leonard A, Magous R, Bali JP.

Biochem Pharmacol. 1990 Jun 15;39(12):1905-11.

PMID:
1693850
14.

Efficacy of prostanoids in the treatment of gastric ulcer.

Rachmilewitz D.

Clin Invest Med. 1987 May;10(3):238-42.

PMID:
3113800
15.

[The effects of nizatidine and misoprostol on peptic activity and gastric mucus].

Grassi SA, Vianello F, Germanà B, Dal Santo P, Faggian D, Battaglia G, Plebani M, Di Mario F, Naccarato R.

Medicina (Firenze). 1990 Jan-Mar;10(1):29-31. Italian.

PMID:
1974318
16.

Sulfonylurea effects on acid and pepsinogen secretion in isolated rabbit gastric glands.

Del Valle JC, Olea J, Pereda C, Gutiérrez Y, Felíu JE, Rossi I.

Eur J Pharmacol. 1998 Feb 19;343(2-3):225-32.

PMID:
9570471
17.

Effect of misoprostol on histamine-stimulated acid secretion and cyclic AMP formation in isolated canine parietal cells.

Tsai BS, Kessler LK, Butchko GM, Bauer RF.

Dig Dis Sci. 1987 Sep;32(9):1010-6.

PMID:
3040357
18.

Effect of trimoprostil on gastric secretion in man.

Ishimori A, Kawamura T, Koizumi F.

Arzneimittelforschung. 1988 Jun;38(6):833-9.

PMID:
3140824
19.

Misoprostol: a prostaglandin E1 analogue.

Garris RE, Kirkwood CF.

Clin Pharm. 1989 Sep;8(9):627-44. Review.

PMID:
2507215
20.

Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.

Tsai BS, Keith RH, Perkins WE, Walsh RE, Anglin CP, Collins PW, Gasiecki AW, Bauer RF, Jones PH, Gaginella TS.

J Pharmacol Exp Ther. 1995 Oct;275(1):368-73.

PMID:
7562572

Supplemental Content

Support Center